Drivers for Healthcare R&D Investment in Asia-Pacific

Rise of the APAC R&D Giants

USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

Investments in Research and Development (R&D) is the key to sustaining innovation and promoting growth in the healthcare industry. Between 2007 and 2012, global investment in R&D in the industry took a detour from US and Europe towards Asia-Pacific (APAC) countries, primarily targeting Australia, Singapore, and South Korea. This research report presents a high-level chronicling of the events and transitions that have led to this trend—the emergence of APAC as a prominent R&D hub.

Table of Contents

Drivers for Healthcare R&D Investment in Asia-PacificDrivers for Healthcare R&D Investment Introduction




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.